Association ofJAK2Mutation Status and Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Myelodysplastic/Myeloproliferative Neoplasms
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association ofJAK2Mutation Status and Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Myelodysplastic/Myeloproliferative Neoplasms
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Volume 135, Issue 5, Pages 709-719
Publisher
Oxford University Press (OUP)
Online
2011-04-19
DOI
10.1309/ajcps6c8evycqnrm
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience
- (2010) B. C. Medeiros et al. BLOOD
- Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
- (2009) Ulrike Bacher et al. ANNALS OF HEMATOLOGY
- International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis
- (2009) K. Hussein et al. BLOOD
- The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course
- (2009) C. S. Tam et al. BLOOD
- Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance
- (2009) Naseema Gangat et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival
- (2009) A Tefferi et al. LEUKEMIA
- Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
- (2009) Federico Lussana et al. THROMBOSIS RESEARCH
- The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
- (2008) J.-J. Kiladjian et al. BLOOD
- Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates
- (2008) Naseema Gangat et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis
- (2008) P. Guglielmelli et al. HAEMATOLOGICA
- Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype
- (2008) Dimitri A. Breems et al. JOURNAL OF CLINICAL ONCOLOGY
- Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival
- (2008) A Tefferi et al. LEUKEMIA
- Oligonucleotide array CGH studies in myeloproliferative neoplasms: Comparison with JAK2V617F mutational status and conventional chromosome analysis
- (2008) Ayalew Tefferi et al. LEUKEMIA RESEARCH
- Systemic Mastocytosis Associated with Chronic Idiopathic Myelofibrosis
- (2007) Karl Sotlar et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started